These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 6626985)

  • 1. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.
    Scatton B; Javoy-Agid F; Rouquier L; Dubois B; Agid Y
    Brain Res; 1983 Sep; 275(2):321-8. PubMed ID: 6626985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chlorpromazine on the metabolism of catecholamines in dog brain.
    Guldberg HC; Yates CM
    Br J Pharmacol; 1969 Jul; 36(3):535-48. PubMed ID: 5789808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine deficiency in the cerebral cortex in Parkinson disease.
    Scatton B; Rouquier L; Javoy-Agid F; Agid Y
    Neurology; 1982 Sep; 32(9):1039-40. PubMed ID: 7202156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine action and disorders of neurotransmitter balance.
    Birkmayer W; Birkmayer JD
    Gerontology; 1987; 33(3-4):168-71. PubMed ID: 3653699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications.
    Sitte HH; Pifl C; Rajput AH; Hörtnagl H; Tong J; Lloyd GK; Kish SJ; Hornykiewicz O
    Eur J Neurosci; 2017 Jan; 45(1):192-197. PubMed ID: 27741357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biogenic amines and metabolites in spinal cord of patients with Parkinson's disease and amyotrophic lateral sclerosis.
    Sofic E; Riederer P; Gsell W; Gavranovic M; Schmidtke A; Jellinger K
    J Neural Transm Park Dis Dement Sect; 1991; 3(2):133-42. PubMed ID: 1716905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates.
    Brown RM; Crane AM; Goldman PS
    Brain Res; 1979 May; 168(1):133-50. PubMed ID: 36962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task.
    Puumala T; Sirviö J
    Neuroscience; 1998 Mar; 83(2):489-99. PubMed ID: 9460757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine changes in the brain of cats during slow-wave sleep.
    Kovacević R; Radulovacki M
    Science; 1976 Sep; 193(4257):1025-7. PubMed ID: 948760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of perinatal hypoxic insult on concentrations of dopamine, serotonin, and metabolites in fetal monkey brain.
    Binienda Z; Fogle CM; Slikker W; Ali SF
    Int J Dev Neurosci; 1994 Apr; 12(2):127-31. PubMed ID: 7524270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
    Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the levels of dopamine, serotonin and their metabolites in the caudate nucleus of the rat.
    Russ H; Henning K; Eckhardt H; Przuntek H
    Arzneimittelforschung; 1985; 35(2):481-2. PubMed ID: 2581589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ketamine on dopamine metabolism during anesthesia in discrete brain regions in mice: comparison with the effects during the recovery and subanesthetic phases.
    Irifune M; Fukuda T; Nomoto M; Sato T; Kamata Y; Nishikawa T; Mietani W; Yokoyama K; Sugiyama K; Kawahara M
    Brain Res; 1997 Jul; 763(2):281-4. PubMed ID: 9296573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain amine concentrations after monoamine oxidase inhibitor administration.
    Jones AB; Pare CM; Nicholson WJ; Price K; Stacey RS
    Br Med J; 1972 Jan; 1(5791):17-9. PubMed ID: 5008339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
    Maruyama W; Naoi M; Narabayashi H
    J Neurol Sci; 1996 Jul; 139(1):141-8. PubMed ID: 8836986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome.
    Johansson B; Roos BE
    Life Sci; 1967 Jul; 6(13):1449-54. PubMed ID: 6035772
    [No Abstract]   [Full Text] [Related]  

  • 17. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease.
    Kish SJ; Tong J; Hornykiewicz O; Rajput A; Chang LJ; Guttman M; Furukawa Y
    Brain; 2008 Jan; 131(Pt 1):120-31. PubMed ID: 17956909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some remarks concerning the possible role of brain monoamines (dopamine, noradrenaline, serotonin) in mental disorders.
    Hornykiewicz O
    J Psychiatr Res; 1974; 11():249-53. PubMed ID: 4282386
    [No Abstract]   [Full Text] [Related]  

  • 19. Endogenous homovanillic acid levels differ between rat and rabbit caudate, hippocampus, and cortical regions.
    Reader TA; Dewar KM
    Neurochem Res; 1989 Nov; 14(11):1137-41. PubMed ID: 2594143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients.
    Scatton B; Dennis T; L'Heureux R; Monfort JC; Duyckaerts C; Javoy-Agid F
    Brain Res; 1986 Aug; 380(1):181-5. PubMed ID: 2428421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.